Bio-Reference Laboratories Inc (BRLI)
Q3 2012 Earnings Call
August 30, 2012 10:30 am ET
Delores Bowman - Acting Investor Relations Coordinator
Marc Grodman - President, CEO, Chairman of the Board
Sam Singer - Senior Vice President, CFO
Sylvia Chao - William Blair
Dane Leone - Macquarie
Raymond Myers - Benchmark
Mitra Ramgopal - Sidoti
Stephen Shankman - UBS
Good day, ladies and gentlemen and welcome to the Bio-Reference Laboratories Incorporated Third Quarter Fiscal Year 2012 Earnings Conference Call. My name is Aaron, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session toward the end of today's conference. (Operator Instructions). As a reminder, this conference is being recorded for replay purposes.
I will now turn the presentation over to your host for today's conference, Ms. Delores Bowman, Acting Investor Relations Coordinator. Please proceed ma'am.
Good morning and welcome to the Bio-Reference Laboratories third quarter 2012 earnings conference call. Bio-Reference Laboratory is one of the largest independent regional full service laboratories in the country with focused marketing capabilities in the areas of genomics, oncology, women's health, correctional health and physician office pathology.
Leading us on the call today will be Dr. Marc Grodman, President and Chief Executive Officer; and Sam Singer, Chief Financial Officer. Some of the commentary made in this presentation may relate to future results and events.
Statements regarding the company's revenue and earnings guidance are based on the company's current expectations. Actual results in future periods may differ materially from those currently expected or desired, because of a number of risks and uncertainties, including general economic and business conditions; future regulatory requirements and mandated pricing reimbursement; the service, customer and geographic market mix of any particular period; the company's ability to effectively manage its operating costs and collect its receivables, the level of demand for the company's products and services and the company's ability to manage its supply and delivery logistics in such an environment.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts